Expandable Bioresorbable Endovascular Stent. I. Fabrication and Properties

AbstractA bioresorbable, expandable poly(L-lactic acid) stent has been designed, based on a linear, continuous coil array principle, by which multiple furled lobes convert to a single lobe upon balloon expansion, without heating. Stent strength and compliance are sufficient to permit deployment by a conventional balloon angioplasty catheter. Several multiple lobe configurations were investigated, with expansion ratios ranging from 1.4 to 1.9 and expanded diameters ranging from 2.3 to 4.7 mm. Compression resistance of the expanded stent is dependent on fiber coil density and fiber ply. A range sufficient for endovascular service was obtained, with less than 4% elastic recoil in six day saline incubation studies. Surface plasma treatment with di(ethylene glycol) vinyl ether significantly reduced platelet adhesion in a 1 h porcine arteriovenous shunt model. Patency was maintained in one week implant studies in the porcine common femoral artery. However, a strong inflammatory response, and significant reduction of the vascular lumen were observed following two weeks implantation. The design principles and fabrication techniques for this bioresorbable stent are sufficiently versatile that a broad range of applications can be addressed. Much work remains to be done, including long-term evaluation of the inflammatory response, and of polymer degradation. The results of this study demonstrate the feasibility of expandable biodegradable stent design and deployment by conventional means. © 2003 Biomedical Engineering Society. PAC2003: 8768+z, 8719Uv

[1]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[2]  J. Griffin,et al.  Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma , 1978, The Journal of experimental medicine.

[3]  G. Tjønnfjord,et al.  Reduced Effect of Aspirin on Thrombus Formation at High Shear and Disturbed Laminar Blood Flow , 1996, Thrombosis and Haemostasis.

[4]  Noninvasive quantification of platelet accumulation and release on indwelling venous catheters. , 1993 .

[5]  H Koyanagi,et al.  In vivo protein adsorption on polymers: visualization of adsorbed proteins on vascular implants in dogs. , 1992, Journal of biomaterials science. Polymer edition.

[6]  Liping Tang,et al.  Review: Bioresorbable polymeric stents: current status and future promise , 2003, Journal of biomaterials science. Polymer edition.

[7]  Patrick W. Serruys,et al.  A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization , 2002 .

[8]  R. Cumming,et al.  A TECHNIQUE FOR THE ELUCIDATION OF VIRCHOW'S TRIAD , 1977 .

[9]  W. J. van der Giessen,et al.  Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. , 1998, Journal of the American College of Cardiology.

[10]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[11]  Robert C. Eberhart,et al.  Bioresorbable Microporous Stents Deliver Recombinant Adenovirus Gene Transfer Vectors to the Arterial Wall , 1998, Annals of Biomedical Engineering.

[12]  R. Eberhart,et al.  Transient adhesion of platelets in pump-oxygenator systems: influence of SMA and nitric oxide treatments. , 1999, Journal of biomaterials science. Polymer edition.

[13]  H. Uehata,et al.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. , 2000, Circulation.

[14]  R. Virmani,et al.  Pathology of acute and chronic coronary stenting in humans. , 1999, Circulation.

[15]  M. Nakamura,et al.  Temporary arterial stenting: comparison to permanent stenting and conventional balloon injury in a rabbit carotid artery model. , 1997, Catheterization and cardiovascular diagnosis.

[16]  P. Boekstegers,et al.  Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation. , 1999, Circulation.

[17]  M. Labinaz,et al.  Biodegradable stents: the future of interventional cardiology? , 1995, Journal of interventional cardiology.

[18]  C M Agrawal,et al.  Deformation characteristics of a bioabsorbable intravascular stent. , 1992, Investigative radiology.

[19]  H. Park,et al.  Morphological characterization of surface-induced platelet activation. , 1990, Biomaterials.

[20]  J. Sixma,et al.  Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. , 1985, The Journal of clinical investigation.

[21]  H. Goldsmith,et al.  Flow Patterns in Vessels of Simple and Complex Geometries a , 1987, Annals of the New York Academy of Sciences.

[22]  R. Kinlough-Rathbone,et al.  Prolonged Expression of Procoagulant Activity of Human Platelets Degranulated by Thrombin , 1995, Thrombosis and Haemostasis.

[23]  H. Bienert,et al.  Development of a New Biodegradable Intravascular Polymer Stent with Simultaneous Incorporation of Bioactive Substances , 1999, The International journal of artificial organs.

[24]  Etienne Schacht,et al.  Biocompatibility of biodegradable and nonbiodegradable polymer-coated stents implanted in porcine peripheral arteries , 1995, CardioVascular and Interventional Radiology.

[25]  T. Tammela,et al.  Bioabsorbable and biodegradable stents in urology. , 1997, Journal of endourology.

[26]  Timmons,et al.  Non-fouling surfaces produced by gas phase pulsed plasma polymerization of an ultra low molecular weight ethylene oxide containing monomer. , 2000, Colloids and surfaces. B, Biointerfaces.

[27]  G. Richter,et al.  Relationship between blood flow, thrombus, and neointima in stents. , 1999, Journal of vascular and interventional radiology : JVIR.

[28]  H Shimokawa,et al.  Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. , 1998, Journal of the American College of Cardiology.

[29]  M. Thakur,et al.  Indium-111-labeled human platelets: improved method, efficacy, and evaluation. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  Catherine Masson,et al.  Radial force of coronary stents: A comparative analysis , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.